Attentional Bias Modification Training for People With Chronic Musculoskeletal Pain
Unknown statusNot applicableNCT02232100
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Chronic musculoskeletal pain is a complex medical condition associated with significant distress, disability, and reduction in quality of life. Research has shown that patients with chronic musculoskeletal pain demonstrate attentional biases towards pain-related information. The purpose of this study is to determine whether internet-delivered attentional bias modification, which aims to implicitly train attention away from pain-related information, has beneficial effects upon pain and pain-related distress in patients with chronic musculoskeletal pain. Participants will be randomised to either an attentional training condition, or to a no-training placebo condition. The primary outcome measures are pain intensity and pain interference, and secondary outcome measures include anxiety, depression, pain-related fear and sleep problems. Data will be analysed and reported separately for participants aged 16 - 24 and 25 - 60. It is hypothesized that participants receiving internet-delivered attentional bias modification will show significantly greater reductions in pain and pain-related distress compared to participants receiving placebo training.
Study details
- Official title
- Internet-Delivered Attentional Bias Modification Training in People With Chronic Musculoskeletal Pain: A Double-Blind Randomised Control Trial and a Qualitative Investigation of Participants' Experience.
- Conditions
- Interventions
- Behavioral: Attentional bias modification training (AMG)
- Behavioral: Attentional bias placebo (ACG)
- Sponsor
- University of Southampton
- Start date
- 2021-11-01
- Primary completion
- 2023-05-01
- Sex
- All
- Age range
- from 16 Years to 60 Years
- Results posted
- No results posted in this snapshot
- Countries
- United Kingdom
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. aged between 16 to 60 years old 2. experiencing any type of CMSK (i.e., any condition that involves pain lasting for more than three months and arises from bones, muscles and/or joints) 3. able to sit at a personal computer for forty minutes 4. normal or corrected to normal vision 5. access to the internet at least twice a week 6. access to, and familiarity using, a Windows-based computer (g) successful completion of primary school 7. living in the United Kingdom. Exclusion Criteria: 1. experiencing malignant CMSK (i.e., pain caused due to a tumour) 2. a diagnosis of any psychiatric disorder, either currently or within the last 5 years 3. currently under psychiatric therapy. No restrictions are placed on concomitant care and participants are not required to make any changes to current treatments they may be receiving.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02232100